Medical News

RSS

Joslin launches initiative for primary care physicians to improve diabetes care

Joslin Diabetes Center has launched a groundbreaking initiative for primary care physicians to improve diabetes care.

3 Mar 2011

Eisai announces publication of Halaven Phase III study results against breast cancer in The Lancet journal

Eisai announced today that results from the global Phase III clinical study "EMBRACE" will be published online in The Lancet.

3 Mar 2011

GHI executive director addresses global health community at Kaiser Family Foundation town hall

In her first public address since being tapped in January to serve as executive director of President Barack Obama's Global Health Initiative, Lois Quam on Tuesday said she's been doing "a lot of listening" to officials at the State Department, PEPFAR, CDC and other agencies about the GHI.

3 Mar 2011

Depomed completes patient enrollment in Breeze 3 Serada Phase 3 trial to treat menopausal hot flashes

Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.

3 Mar 2011

ContextVision launches two breast cancer diagnostic imaging solutions at ECR 2011

ContextVision, the software imaging partner for the most recognized medical imaging manufacturers worldwide, today introduced two innovative solutions at the 2011 European Congress of Radiology.

3 Mar 2011

Two reasons motivate rural Appalachian women to perform breast health self-examinations

In an effort to develop strategies for breast health awareness in rural populations researchers asked the question, "What message strategies will motivate Appalachian women to attend to breast health issues and become actively involved in their own breast health?"

3 Mar 2011

New research: Weight discrimination may impact physical health

The discrimination that obese people feel, whether it is poor service at a restaurant or being treated differently in the workplace, may have a direct impact on their physical health, according to new research from Purdue University.

3 Mar 2011

iCAD to showcase its cancer diagnostic imaging products at ECR annual meeting

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.

3 Mar 2011

Scientists find reprogramming-associated mutations in hiPSCs

Ordinary human cells reprogrammed as induced pluripotent stem cells may ultimately revolutionize personalized medicine by creating new and diverse therapies unique to individual patients.

3 Mar 2011

Lancet Infectious Diseases examines how resource gaps are creating barriers to reduce child mortality

The Lancet Infectious Diseases' Newsdesk examines how resource gaps in immunizations, health workers and financing are creating barriers to efforts to achieve the U.N. Millennium Development Goal target to reduce child mortality by two-thirds by 2015, as highlighted in a recent Save the Children report.

3 Mar 2011

PositiveID reaches chemistry milestone in glucose-sensing RFID microchip development

PositiveID Corporation announced today that it has reached an important chemistry milestone in the development of its GlucoChip, glucose-sensing RFID microchip.

3 Mar 2011

New Sanitized MedX 200s active ingredient series to reduce risk of HAI

The new Sanitized MedX 200s active ingredient series, which has been used with success in the plastics of medical equipment, makes a contribution to reducing the risk of Healthcare-Associated Infections, HAI.

3 Mar 2011

Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines

Celerion, the premier provider of innovative early stage drug development solutions, announces the completion of a Clean Room and pharmacist certification to comply with USP 797 guidelines.

3 Mar 2011

Groundbreaking discovery in lymphoma research

BC Cancer Agency scientists have discovered that a single gene, CIITA, is implicated in almost 40 per cent of primary mediastinal B-cell lymphomas and 15 per cent of all Hodgkin lymphoma cases.

3 Mar 2011

1099 repeal measure's pay-for mechanism triggers democratic concern

With a House vote scheduled for Thursday, the White House is on record opposing the "offset" used to pay for the repeal of this reporting provision included in the health law, but it also stopped short of threatening a veto. This part of the bill also may cause it to lose bipartisan support in the lower chamber.

3 Mar 2011

CTI meets officials of FDA's OND to support pixantrone NDA

Cell Therapeutics, Inc. today announced that it has met with officials of the FDA's Office of New Drugs in Maryland and presented its arguments supporting the Company's belief that the data contained in its New Drug Application 22-481 support the conclusion that pixantrone is effective for its planned use.

3 Mar 2011

Lixte receives $244,479.25 U.S. government grant for QTDP program

Lixte Biotechnology Holdings announced today that the company has received a $244,479.25 grant under the Qualifying Therapeutic Discovery Project.

3 Mar 2011

New study examines boxing injuries among children and adolescents from 1990 to 2008

The risk and nature of injury in the sport of boxing has generated a great deal of controversy in the medical community, especially in relation to youth boxing. A new study, conducted by researchers in the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital, examined boxing injuries among participants 6 years of age and older from 1990 to 2008.

3 Mar 2011

Rates of cerebral palsy decline among children born prematurely

Cerebral palsy is a neurodevelopmental condition that affects motor function, more often in children born prematurely. Because cerebral palsy is a result of brain injury received shortly before, during, or soon after birth, the number of infants being diagnosed with the condition is a good indicator of the quality of perinatal and neonatal care. An article soon to be published in The Journal of Pediatrics indicates that the rates of cerebral palsy have declined dramatically in the past 15 years.

3 Mar 2011

Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV

Vertex Pharmaceuticals Incorporated announced today interim results from an ongoing, two-part, Phase 2 study evaluating telaprevir in combination with pegylated-interferon and ribavirin compared to pegylated-interferon and ribavirin alone in people who are infected with both genotype 1 hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.

3 Mar 2011

Medical News

Joslin launches initiative for primary care physicians to improve diabetes care

Eisai announces publication of Halaven Phase III study results against breast cancer in The Lancet journal

GHI executive director addresses global health community at Kaiser Family Foundation town hall

Depomed completes patient enrollment in Breeze 3 Serada Phase 3 trial to treat menopausal hot flashes

ContextVision launches two breast cancer diagnostic imaging solutions at ECR 2011

Two reasons motivate rural Appalachian women to perform breast health self-examinations

New research: Weight discrimination may impact physical health

iCAD to showcase its cancer diagnostic imaging products at ECR annual meeting

Scientists find reprogramming-associated mutations in hiPSCs

Lancet Infectious Diseases examines how resource gaps are creating barriers to reduce child mortality

PositiveID reaches chemistry milestone in glucose-sensing RFID microchip development

New Sanitized MedX 200s active ingredient series to reduce risk of HAI

Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines

Groundbreaking discovery in lymphoma research

1099 repeal measure's pay-for mechanism triggers democratic concern

CTI meets officials of FDA's OND to support pixantrone NDA

Lixte receives $244,479.25 U.S. government grant for QTDP program

New study examines boxing injuries among children and adolescents from 1990 to 2008

Rates of cerebral palsy decline among children born prematurely

Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News